Federated Hermes’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Federated Hermes’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-470,000	Closed	-$11.4M	–	2258
2023 Q1	$11.4M	Buy	+470,000	New	+$10.3M	0.03%	514
2022 Q2	–	Sell	-1,888	Closed	-$32K	–	2328
2022 Q1	$32K	Sell	1,888 -257	-12%	-$3.8K	﹤0.01%	1785
2021 Q4	$36K	Sell	2,145 -2,122	-50%	-$34.8K	﹤0.01%	1825
2021 Q3	$70K	Buy	+4,267	New	+$46.4K	﹤0.01%	1823
2021 Q2	–	Sell	-7,021	Closed	-$43K	–	2368
2021 Q1	$43K	Buy	7,021 +2,436	+53%	+$14.8K	﹤0.01%	1886
2020 Q4	$32K	Buy	4,585 +366	+9%	+$2.34K	﹤0.01%	1867
2020 Q3	$24K	Buy	4,219 +3,946	+1,445%	+$18.8K	﹤0.01%	1878
2020 Q2	$1K	Buy	273 +102	+60%	+$425	﹤0.01%	2198
2020 Q1	$1K	Sell	171 -50	-23%	-$292	﹤0.01%	2182
2019 Q4	$2K	Buy	221 +34	+18%	+$121	﹤0.01%	2051
2019 Q3	$1K	Sell	187 -446	-70%	-$519	﹤0.01%	2156
2019 Q2	$1K	Sell	633 -72	-10%	-$99	﹤0.01%	2133
2019 Q1	$1K	Sell	705 -624	-47%	-$873	﹤0.01%	2125
2018 Q4	$2K	Sell	1,329 -914	-41%	-$1.77K	﹤0.01%	2096
2018 Q3	$5K	Sell	2,243 -2,939	-57%	-$7.33K	﹤0.01%	2065
2018 Q2	$14K	Sell	5,182 -30,177	-85%	-$83.3K	﹤0.01%	1865
2018 Q1	$97K	Sell	35,359 -19,994	-36%	-$58K	﹤0.01%	1595
2017 Q4	$173K	Sell	55,353 -905	-2%	-$2.54K	﹤0.01%	1535
2017 Q3	$159K	Buy	56,258 +797	+1%	+$2.15K	﹤0.01%	1532
2017 Q2	$142K	Buy	55,461 +28,040	+102%	+$76.4K	﹤0.01%	1569
2017 Q1	$100K	Buy	+27,421	New	+$116K	﹤0.01%	1565
2015 Q4	–	Sell	-10,000	Closed	-$405K	–	2174
2015 Q3	$405K	Hold	10,000	–	–	﹤0.01%	1340
2015 Q2	$521K	Sell	10,000 -11,108	-53%	-$553K	﹤0.01%	1319
2015 Q1	$982K	Sell	21,108 -7,630	-27%	-$396K	﹤0.01%	1182
2014 Q4	$1.29M	Buy	28,738 +15,738	+121%	+$661K	﹤0.01%	1101
2014 Q3	$506K	Sell	13,000 -7,000	-35%	-$275K	﹤0.01%	1357
2014 Q2	$846K	Buy	20,000 +5,000	+33%	+$183K	﹤0.01%	1220
2014 Q1	$536K	Buy	+15,000	New	+$506K	﹤0.01%	1330

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Federated Hermes's ISEE Position: Q2 2023 in Review

Federated Hermes sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 470,000 shares — an estimated $11.4M sold.

Federated Hermes first reported a position in ISEE in Q1 2014 and held it in 28 quarters. The position peaked at $11.4M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Federated Hermes reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Federated Hermes sold 470,000 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $11.4M.
Federated Hermes first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 28 quarters.
Federated Hermes's IVERIC bio, Inc. Common Stock position peaked at $11.4M in Q1 2023.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.